Resources will speed the expansion of digital health products worldwide,improving global patient access
SYRACUSE,N.Y.,Nov. 19,2024-- In a landscape marked by intense competition,rising costs,and stringent regulatory requirements,independent pharmacies face an array of challenges that threaten their viab
TURFAN,China,Nov. 18,2024-- On November 15,in the transmission safety monitoring center of the State Grid Turfan Power Supply Company,the power supply personnel used the AI real-world monitoring devic
SINGAPORE,Nov. 18,2024--The Singapore Management University(SMU) hosted the third RI-SING University Network (RUN) meeting on 12-13 November 2024,bringing together top educational leaders from Singap
Helping CISOs Select Top-Performing Cybersecurity Solutions with Rigorous Advanced Threat Protection Testing Results for 2024
BOLINGBROOK,Ill.,Nov. 18,2024--Stock up your family\'s medicine cabinet this Black Friday and Cyber Monday. WELLlife,a leading innovator in medical diagnostic and testing solutions,is increasing acces
HONG KONG,Nov. 19,2024-- The highly anticipated Hong Kong FashionFest,running from 20 November to 4 December 2024,is set to take over the city with an expansive programme celebrating fashion,creativi
MELBOURNE,Australia,Nov. 19,2024-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces it will expand its theranostic pipeline with new assets targeting Fibroblast
-Third Quarter Total Transaction Volume reached RMB52.2 billion,up 1.8% year-over-year- -Third Quarter International Transaction Volume reached RMB2.7 billion,up 22.7% year-over-year-
78-Week results from Phase III randomized controlled trial (RCT) including switching data from reference denosumab to CT-P41 (biosimilar candidate of denosumab) demonstrate comparable efficacy and sa
Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.
©copyright 2009-2020 Sir Daily Contact Us SiteMap